Intas has developed COVID-19 specific Hyperimmune Globulin as treatment for patients suffering from moderate to severe COVID-19 infection... Aug 27
The portfolio acquired from INTAS comprises eight US FDA approved ANDAs and two products pending approval ... Jun 13
The Proposed Combination relates to acquisition of less than 5% shareholding ofIntas Pharmaceuticals Limited (Intas) by Canary Investments Limited (Canary) and Link Investment Trust II (... May 01
-Advertisements-